Provided by Tiger Trade Technology Pte. Ltd.

Adicet Bio, Inc.

9.26
0.0000
Pre-market: 9.340.0800+0.86%04:29 EDT
Volume:60.95K
Turnover:570.22K
Market Cap:86.56M
PE:-0.88
High:9.65
Open:9.35
Low:9.00
Close:9.26
52wk High:17.44
52wk Low:6.01
Shares:9.35M
Float Shares:8.42M
Volume Ratio:0.41
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.5201
EPS(LYR):-16.9493
ROE:-78.08%
ROA:-41.66%
PB:0.72
PE(LYR):-0.55

Loading ...

Adicet Bio CEO Joins H.C. Wainwright Global Investment Conference Fireside Chat

Reuters
·
15 hours ago

Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET) and TG Therapeutics (TGTX)

TIPRANKS
·
Yesterday

Adicet Bio to Report Prula-Cel Phase 1 Lupus Topline Data in September 2026

Reuters
·
Sep 01

Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of Prula-Cel (Formerly Adi-001) Study in Patients with Systemic Lupus Erythematosus with or Without Lupus Nephritis and Provides Corporate Update

THOMSON REUTERS
·
Sep 01

Adicet Bio: Prula-Cel Topline Results from Planned Analysis Expected September 2026

THOMSON REUTERS
·
Sep 01

Adicet Bio - Expects to Advance First Candidate from Its in Vivo CAR-T Portfolio into Clinical Development in Second Half of 2027

THOMSON REUTERS
·
Sep 01

Adicet Bio Grants New-Hire Stock Options for 1,500 Shares at $8.7 Each Under Inducement Plan

Reuters
·
Sep 01

Adicet Bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 01

Adicet Bio Wins FDA IND Clearance for ADI-212 Prostate Cancer Trial

Reuters
·
Aug 28

Adicet Bio Announces FDA Clearance of Ind Application for Adi-212

THOMSON REUTERS
·
Aug 28

Adicet Bio, - to Begin Phase 1 Enrollment for Adi-212 in Mcrpc in Q4 2026

THOMSON REUTERS
·
Aug 28

Analysts’ Top Healthcare Picks: Collegium Pharmaceutical (COLL), Adicet Bio (ACET)

TIPRANKS
·
Aug 07

Adicet Bio, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Adicet Bio Q2 EPS $(1.99) Beats $(2.03) Estimate

Benzinga Earnings
·
Aug 06

Adicet Bio Q2 FY26 Net Loss Widens to $21.4 Million; Cash and Short-Term Investments Total $118.2 Million

Reuters
·
Aug 06

Adicet Bio Q2 Basic EPS USD -1.99

Reuters
·
Aug 06

Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 06

Adicet Bio Inc Expected to Post a Loss of $2.03 a Share - Earnings Preview

Reuters
·
Aug 03

Analysts’ Top Healthcare Picks: Molina Healthcare (MOH), Adicet Bio (ACET)

TIPRANKS
·
Jul 13

Adicet Bio shareholders elect three Class II directors at annual meeting

Reuters
·
Jun 19